Article

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

2022-05-25

Abstract excerpt

To control the coronavirus disease 2019 (COVID-19) pandemic, there is a need to develop vaccines to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. One candidate is a nasal vaccine capable of inducing secretory IgA antibodies in the mucosa of the upper respiratory tract, the initial site of infection. However, regarding the development of COVID-19 vaccines, there is co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fb36dcfc-13c1-5489-8871-1c545762c4ed
DOI: 10.1101/2022.05.24.493348

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathologyDOI 10.1101/2022.05.24.493348Read

Comprehensive analysis of nasal IgA antibodies induced by intranasal administration of the SARS-CoV-2 spike proteinSemantic proximity Read

Mucosal vaccination for SARS-CoV-2 elicits superior systemic T central memory function and cross-neutralizing antibodies against variants of concernSemantic proximity Read

Unadjuvanted intranasal spike vaccine booster elicits robust protective mucosal immunity against sarbecovirusesSemantic proximity Read

Intramuscular COVID-19 Vaccination Elicits SARS-CoV-2 Spike-Specific CD8 <sup> </sup> Tissue-Resident Memory T Cells in the Nasal TissueSemantic proximity Read

A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent PatientsSemantic proximity Read

Intranasal Nanoemulsion Adjuvanted S-2P Vaccine Demonstrates Protection in Hamsters and Induces Systemic, Cell-Mediated and Mucosal Immunity in MiceSemantic proximity Read

Intranasal Vaccination with a Lentiviral Vector Strongly Protects against SARS-CoV-2 in Mouse and Golden Hamster Preclinical ModelsSemantic proximity Read

Mixed lipopeptide-based mucosal vaccine candidate induces cross-variant immunity and protects against SARS-CoV-2 infection in hamstersSemantic proximity Read

Active and Passive Immunization of Syrian Hamsters with An Attenuated SARS-CoV-2 Protects against New Variants of ConcernSemantic proximity Read

A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent PatientsSemantic proximity Read

A SARS CoV-2 nucleocapsid vaccine protects against distal viral disseminationSemantic proximity Read

Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccinationSemantic proximity Read